Delivery Order SPE2DB22D1017-SPE2DB25FYRYA
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,539.30 by the Defense Logistics Agency's Medical Supply Chain on June 2, 2025, for the supply of Abiraterone Acetate 250 mg tablets (120-count). This competitively awarded, non-set-aside contract carries a firm fixed price and is scheduled for completion by June 3, 2025. The award represents a continuation of AmerisourceBergen's substantial role as a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $3,398.61 to AmerisourceBergen Drug Corp for the supply of Abiraterone Acetate 500 mg tablets (60-count units) on June 12, 2025, with completion scheduled for June 13, 2025. The contract utilizes firm fixed price terms and is not designated as a set-aside award, indicating it was competitively awarded. The pharmaceutical will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $96,898.94 to AmerisourceBergen Drug Corp for the supply of Abiroterone Acetate 250 mg tablets (120-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 22, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $37,489.04 to AmerisourceBergen Drug Corp for the supply of Abiroterone Acetate 250 mg tablets (120-count units) under a firm fixed-price contract. This non-competitive delivery order, issued on August 6, 2025, with an ultimate completion date of August 7, 2025, represents a pharmaceutical procurement supporting federal medical supply needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Abiraterone Acetate 250 mg tablets (120-count units) valued at $1,488.86. This firm fixed-price delivery order is expected to reach completion by August 15, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting the vendor's capability to meet...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on June 17, 2025, for Abiroterone Acetate 500 mg tablets (60-count) with a ceiling value of $17,936.40. This non-set-aside, competitively awarded delivery order utilizes firm fixed pricing and carries an ultimate completion date of June 18, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Abiraterone Acetate 500 mg tablets (60 count) with a ceiling value of $13,456.36. This is a firm fixed price delivery order with no set-aside designation, completed competitively, with a performance location in Conshohocken, Pennsylvania and an ultimate completion date of September 10, 2025. The award represents a single delivery order issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 17, 2025, for the supply of Abiraterone Acetate 250 mg tablets (120-count) with a ceiling value of $1,783.60. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract through open competition. The order is scheduled for completion by July 18, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Abiroterone Acetate 250 mg tablets (120-count packages) with a ceiling value of $184,749.89. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of July 22, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Abiraterone Acetate 250 mg tablets (120-count) with a ceiling value of $3,567.24. This competitively awarded, firm fixed-price contract was executed on July 22, 2025, with an ultimate completion date of July 23, 2025. The pharmaceutical product will be delivered from the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FYRYADelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Abiraterone Acetate 500 mg tablets (60-count) valued at $3,930.29. The contract is firm fixed price with no set-aside designation, competitively awarded, and scheduled for completion by September 26, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company maintains an extensive portfolio of federal contract awards predominantly with the Defense Logistics Agency, delivering pharmaceutical products spanning multiple therapeutic domains including specialty medications, brand-name and generic drugs, vaccines, and medical supplies. The firm's federal contracts are consistently awarded on a non-set-aside, competitive basis with delivery order structures and firm fixed pricing, demonstrating its capability to meet federal procurement requirements. This award supports the Defense Health Agency and other government healthcare systems through the flexible DLA Troop Support Medical contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 9/25/25 |